fluphenazine and Acathisia, Drug-Induced studies

fluphenazine and Acathisia, Drug-Induced

Research Excerpts

Excerpt	Relevance	Reference
"To compare the effects of oral fluphenazine with placebo for the treatment of schizophrenia."	8.98	Fluphenazine (oral) versus placebo for schizophrenia. ( Almerie, MQ; Matar, HE; Sampson, SJ, 2018)
"To review the effects of fluphenazine and low-potency antipsychotics for people with schizophrenia."	8.90	Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia. ( Engel, RR; Huhn, M; Leucht, S; Tardy, M, 2014)
"Fifty-three patients with acute exacerbations of Research Diagnostic Criteria schizophrenic, schizoaffective (mainly schizophrenic), and other nonaffective psychoses completed 24 or 28 days of treatment with randomized, fixed, double-blind doses of 10, 20, or 30 mg of oral fluphenazine hydrochloride daily."	5.06	Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment. ( Jain, A; Levinson, DF; Silver, P; Simpson, GM; Singh, H; Stephanos, MJ; Yadalam, K, 1990)
"To compare the effects of oral fluphenazine with placebo for the treatment of schizophrenia."	4.98	Fluphenazine (oral) versus placebo for schizophrenia. ( Almerie, MQ; Matar, HE; Sampson, SJ, 2018)
"To review the effects of fluphenazine and low-potency antipsychotics for people with schizophrenia."	4.90	Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia. ( Engel, RR; Huhn, M; Leucht, S; Tardy, M, 2014)
"Oral fluphenazine was given in fixed, randomized, double-blind doses (10, 20, or 30 mg/day) for 4 weeks to 72 inpatients with acute schizophrenic exacerbations."	2.68	Fluphenazine plasma levels, dosage, efficacy, and side effects. ( Cooper, TB; Levinson, DF; Lo, ES; Simpson, GM; Singh, H; Stephanos, MJ; Yadalam, K, 1995)
"During long-term treatment of schizophrenia with antipsychotic medication, side effects such as weight gain and tardive dyskinesia may develop, while other extrapyramidal side effects may continue."	2.67	Side effects during long-term treatment with depot antipsychotic medication. ( Cookson, JC, 1991)
" There was no significant difference in survival when the clinician was permitted to make a dosage adjustment up to 10 mg in the low-dose group and 50 mg in the higher-dose group when the patient demonstrated evidence of a symptomatic exacerbation."	2.66	Low- and conventional-dose maintenance therapy with fluphenazine decanoate. Two-year outcome. ( Lebell, M; Marder, SR; May, PR; McKenzie, J; Mintz, J; Van Putten, T, 1987)

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (42.86)	18.7374
1990's	5 (35.71)	18.2507
2000's	1 (7.14)	29.6817
2010's	2 (14.29)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

6 (42.86)

18.7374

1990's

5 (35.71)

18.2507

2000's

1 (7.14)

29.6817

2010's

2 (14.29)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Matar, HE	1
Almerie, MQ	1
Sampson, SJ	1
Tardy, M	1
Huhn, M	1
Engel, RR	1
Leucht, S	1
Stryjer, R	1
Grupper, D	1
Strous, R	1
Poyurovsky, M	1
Weizman, A	1
Weiner, WJ	1
Luby, ED	1
Shear, MK	1
Frances, A	1
Weiden, P	1
Levinson, DF	2
Simpson, GM	2
Lo, ES	1
Cooper, TB	1
Singh, H	2
Yadalam, K	2
Stephanos, MJ	2
Ketai, R	1
Jose, C	1
Mallya, A	1
Mehta, D	1
Evenson, R	1
Holland, R	1
Kane, J	1
Quitkin, F	1
Rifkin, A	1
Klein, DF	1
Cookson, JC	1
Marder, SR	2
Midha, KK	1
Van Putten, T	2
Aravagiri, M	1
Hawes, EM	1
Hubbard, JW	1
McKay, G	1
Mintz, J	2
Jain, A	1
Silver, P	1
Lebell, M	1
McKenzie, J	1
May, PR	1
Drake, RE	1
Ehrlich, J	1

Studies

Matar, HE

Almerie, MQ

Sampson, SJ

Tardy, M

Huhn, M

Engel, RR

Leucht, S

Stryjer, R

Grupper, D

Strous, R

Poyurovsky, M

Weizman, A

Weiner, WJ

Luby, ED

Shear, MK

Frances, A

Weiden, P

Levinson, DF

Simpson, GM

Lo, ES

Cooper, TB

Singh, H

Yadalam, K

Stephanos, MJ

Ketai, R

Jose, C

Mallya, A

Mehta, D

Evenson, R

Holland, R

Kane, J

Quitkin, F

Rifkin, A

Klein, DF

Cookson, JC

Marder, SR

Midha, KK

Van Putten, T

Aravagiri, M

Hawes, EM

Hubbard, JW

McKay, G

Mintz, J

Jain, A

Silver, P

Lebell, M

McKenzie, J

May, PR

Drake, RE

Ehrlich, J

Reviews

2 reviews available for fluphenazine and Acathisia, Drug-Induced

Article	Year
Fluphenazine (oral) versus placebo for schizophrenia. The Cochrane database of systematic reviews, 2018, 06-12, Volume: 6 Topics: Administration, Oral; Akathisia, Drug-Induced; Antipsychotic Agents; Fluphenazine; Humans; Placebos;	2018
Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia. The Cochrane database of systematic reviews, 2014, Aug-03, Issue:8 Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Dyskinesia, Drug-Induced; Fluphenazine; Humans; Rando	2014

Article

Year

Fluphenazine (oral) versus placebo for schizophrenia.

The Cochrane database of systematic reviews, 2018, 06-12, Volume: 6

Topics: Administration, Oral; Akathisia, Drug-Induced; Antipsychotic Agents; Fluphenazine; Humans; Placebos;

2018

Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia.

The Cochrane database of systematic reviews, 2014, Aug-03, Issue:8

Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Dyskinesia, Drug-Induced; Fluphenazine; Humans; Rando

2014

Trials

5 trials available for fluphenazine and Acathisia, Drug-Induced

Article	Year
Fluphenazine plasma levels, dosage, efficacy, and side effects. The American journal of psychiatry, 1995, Volume: 152, Issue:5 Topics: Acute Disease; Administration, Oral; Adult; Akathisia, Drug-Induced; Basal Ganglia Diseases; Dose-Re	1995
Side effects during long-term treatment with depot antipsychotic medication. Clinical neuropharmacology, 1991, Volume: 14 Suppl 2 Topics: Akathisia, Drug-Induced; Delayed-Action Preparations; Double-Blind Method; Dyskinesia, Drug-Induced;	1991
Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response. The British journal of psychiatry : the journal of mental science, 1991, Volume: 158 Topics: Adult; Akathisia, Drug-Induced; Delayed-Action Preparations; Dose-Response Relationship, Drug; Doubl	1991
Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment. Archives of general psychiatry, 1990, Volume: 47, Issue:8 Topics: Acute Disease; Akathisia, Drug-Induced; Basal Ganglia Diseases; Dose-Response Relationship, Drug; Dr	1990
Low- and conventional-dose maintenance therapy with fluphenazine decanoate. Two-year outcome. Archives of general psychiatry, 1987, Volume: 44, Issue:6 Topics: Adult; Akathisia, Drug-Induced; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Indu	1987

Article

Year

Fluphenazine plasma levels, dosage, efficacy, and side effects.

The American journal of psychiatry, 1995, Volume: 152, Issue:5

Topics: Acute Disease; Administration, Oral; Adult; Akathisia, Drug-Induced; Basal Ganglia Diseases; Dose-Re

1995

Side effects during long-term treatment with depot antipsychotic medication.

Clinical neuropharmacology, 1991, Volume: 14 Suppl 2

Topics: Akathisia, Drug-Induced; Delayed-Action Preparations; Double-Blind Method; Dyskinesia, Drug-Induced;

1991

Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response.

The British journal of psychiatry : the journal of mental science, 1991, Volume: 158

Topics: Adult; Akathisia, Drug-Induced; Delayed-Action Preparations; Dose-Response Relationship, Drug; Doubl

1991

Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment.

Archives of general psychiatry, 1990, Volume: 47, Issue:8

Topics: Acute Disease; Akathisia, Drug-Induced; Basal Ganglia Diseases; Dose-Response Relationship, Drug; Dr

1990

Low- and conventional-dose maintenance therapy with fluphenazine decanoate. Two-year outcome.

Archives of general psychiatry, 1987, Volume: 44, Issue:6

Topics: Adult; Akathisia, Drug-Induced; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Indu

1987

Other Studies

7 other studies available for fluphenazine and Acathisia, Drug-Induced

Article	Year
Mianserin for the rapid improvement of chronic akathisia in a schizophrenia patient. European psychiatry : the journal of the Association of European Psychiatrists, 2004, Volume: 19, Issue:4 Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Chronic Disease; Fluphenazine; Humans; Male; Middle A	2004
Persistent akathisia following neuroleptic withdrawal. Annals of neurology, 1983, Volume: 13, Issue:4 Topics: Akathisia, Drug-Induced; Female; Fluphenazine; Humans; Middle Aged; Parkinson Disease	1983
Suicide associated with akathisia and depot fluphenazine treatment. Journal of clinical psychopharmacology, 1983, Volume: 3, Issue:4 Topics: Adult; Akathisia, Drug-Induced; Dyskinesia, Drug-Induced; Fluphenazine; Humans; Male; Psychomotor Ag	1983
Interaction between fluoxetine and neuroleptics. The American journal of psychiatry, 1993, Volume: 150, Issue:5 Topics: Akathisia, Drug-Induced; Basal Ganglia Diseases; Drug Interactions; Fluoxetine; Fluphenazine; Humans	1993
Iatrogenic morbidity in patients taking depot fluphenazine. The American journal of psychiatry, 1979, Volume: 136, Issue:7 Topics: Adult; Age Factors; Aged; Akathisia, Drug-Induced; Basal Ganglia Diseases; Delayed-Action Preparatio	1979
Comparison of the incidence and severity of extrapyramidal side effects with fluphenazine enanthate and fluphenazine decanoate. The American journal of psychiatry, 1978, Volume: 135, Issue:12 Topics: Adolescent; Adult; Akathisia, Drug-Induced; Ambulatory Care; Basal Ganglia Diseases; Decanoates; Del	1978
Suicide attempts associated with akathisia. The American journal of psychiatry, 1985, Volume: 142, Issue:4 Topics: Adult; Akathisia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Impulsive Behavior; Male;	1985

Article

Year

Mianserin for the rapid improvement of chronic akathisia in a schizophrenia patient.

European psychiatry : the journal of the Association of European Psychiatrists, 2004, Volume: 19, Issue:4

Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Chronic Disease; Fluphenazine; Humans; Male; Middle A

2004

Persistent akathisia following neuroleptic withdrawal.

Annals of neurology, 1983, Volume: 13, Issue:4

Topics: Akathisia, Drug-Induced; Female; Fluphenazine; Humans; Middle Aged; Parkinson Disease

1983

Suicide associated with akathisia and depot fluphenazine treatment.

Journal of clinical psychopharmacology, 1983, Volume: 3, Issue:4

Topics: Adult; Akathisia, Drug-Induced; Dyskinesia, Drug-Induced; Fluphenazine; Humans; Male; Psychomotor Ag

1983

Interaction between fluoxetine and neuroleptics.

The American journal of psychiatry, 1993, Volume: 150, Issue:5

Topics: Akathisia, Drug-Induced; Basal Ganglia Diseases; Drug Interactions; Fluoxetine; Fluphenazine; Humans

1993

Iatrogenic morbidity in patients taking depot fluphenazine.

The American journal of psychiatry, 1979, Volume: 136, Issue:7

Topics: Adult; Age Factors; Aged; Akathisia, Drug-Induced; Basal Ganglia Diseases; Delayed-Action Preparatio

1979

Comparison of the incidence and severity of extrapyramidal side effects with fluphenazine enanthate and fluphenazine decanoate.

The American journal of psychiatry, 1978, Volume: 135, Issue:12

Topics: Adolescent; Adult; Akathisia, Drug-Induced; Ambulatory Care; Basal Ganglia Diseases; Decanoates; Del

1978

Suicide attempts associated with akathisia.

The American journal of psychiatry, 1985, Volume: 142, Issue:4

Topics: Adult; Akathisia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Impulsive Behavior; Male;

1985